Vera Therapeutics, Inc. VERA
32.54
(0.80)
(2.40%)
as of 25 Sep
- Market cap
- $2.4B
- P/E
- 0.0×
Follow VERA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
12.21 | 13.64 | 13.64 | 10.92 |
Net Debt/EBITDA |
5.01 | 6.77 | 4.17 | 3.76 | |
Debt/Assets |
14.42% | 10.19% | 12.07% | 14.11% | |
Debt/Equity |
0.19 | 0.12 | 0.15 | 0.18 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.77 | 0.77 | 0.88 | 0.92 | |
Capex/Depreciation |
0.28 | 0.30 | 2.70 | 0.36 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.97) | (1.09) | (1.49) | (1.40) | |
Cash per Share |
7.79 | 11.12 | 8.35 | 6.95 | |
Shareholders Equity per Share |
6.25 | 9.41 | 6.99 | 5.68 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.25 | 9.41 | 6.99 | 5.68 | |
Free Cash Flow |
(62.04) | (70.10) | (106.67) | (100.37) | |
Working Capital |
469.43 | 675.43 | 570.65 | 479.17 | |
Capital Expenditures |
(0.13) | (0.10) | (0.17) | (0.11) | |
Net Current Asset Value |
392.69 | 598.67 | 493.76 | 402.27 | |
| Other line items | |||||
Quick Ratio |
11.88 | 13.37 | 13.22 | 10.33 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.97) | (1.09) | (1.49) | (1.40) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
11.28 | 14.78 | 11.59 | 13.87 | |
Average Assets |
443.03 | 695.21 | 615.95 | 555.76 | |
Average Common Equity |
343.97 | 590.84 | 517.35 | 438.02 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates